Description

1. Product Overview: Tarvidex is a capsule formulation of Valbenazine 40 mg, a selective VMAT2 inhibitor used for the treatment of tardive dyskinesia, a movement disorder associated with prolonged use of certain antipsychotic medications.
2. Composition: Active Ingredient: Valbenazine 40 mg | Dosage Form: Capsule
3. Pharmacological Class: VMAT2 (Vesicular Monoamine Transporter 2) Inhibitor
4. Mechanism of Action: Valbenazine selectively inhibits VMAT2, reducing the release of dopamine in synaptic vesicles, which helps decrease abnormal involuntary movements associated with tardive dyskinesia.
5. Indications: Tardive dyskinesia in adults
6. Dosage & Administration: As prescribed by physician | Oral use | Once daily dosing | Can be taken with or without food
7. Clinical Benefits: Reduces involuntary movements | Improves motor control | Enhances quality of life in affected patients
8. Contraindications: Hypersensitivity to Valbenazine or any component
9. Precautions: Monitor for somnolence and QT prolongation | Use caution in patients with cardiac conditions | Avoid use with strong CYP3A4 inhibitors without adjustment
10. Drug Interactions: CYP3A4 inhibitors/inducers may alter drug levels | Avoid concurrent use with MAO inhibitors
11. Special Populations: Pregnancy: Use only if necessary | Lactation: Consult physician | Dose adjustment may be required in hepatic impairment
12. Adverse Effects: Somnolence | Fatigue | Dry mouth | Headache
13. Storage Conditions: Store below 30°C | Protect from light and moisture | Keep out of reach of children
14. Packaging: Capsule in blister pack
15. Manufacturer: Everest Pharmaceutical Ltd.